1.) Do we need to worry about how long it takes to deploy capital? If a patient philanthropist encounters a “hinge”, will there be enough pre-existing institutions to be able to take advantage of it?
2.) How much should we value the information gained from acting now and “learning by doing” about what works?
3.) I imagine there also should be value for a patient philanthropist to still donate considerably to research now, so we can better identify “hinges” and know how and where to take advantage of them.
1.) Do we need to worry about how long it takes to deploy capital? If a patient philanthropist encounters a “hinge”, will there be enough pre-existing institutions to be able to take advantage of it?
2.) How much should we value the information gained from acting now and “learning by doing” about what works?
3.) I imagine there also should be value for a patient philanthropist to still donate considerably to research now, so we can better identify “hinges” and know how and where to take advantage of them.